Rebif Injection, Solution
Product Images NDC 44087-0022

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Rebif (NDC 44087-0022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rebif 01)

A Kaplan-Meier curve comparing the proportion of disease progression over two years among patients receiving REBIF injections at 22 mcg and 44 mcg dosages versus placebo. The graph shows lower progression rates for both REBIF dosages (26% and 29%) compared to placebo (37%), with statistical significance values (p=0.01 for 44 mcg and p=0.04 for 22 mcg) indicated in a legend box.*

FDA Label Image

Firgure A (Rebif 02)

An instructional line drawing illustrating the components of a syringe assembly including the plunger, syringe barrel, needle, and needle cap arranged sequentially from left to right.*

FDA Label Image

Firgure B (Rebif 03)

An instructional illustration showing items related to the injection process for REBIF (interferon beta-1a) subcutaneous injection. It includes a prefilled syringe, adhesive bandage strip, alcohol pad or rubbing alcohol with cotton balls, a puncture resistant safety container, and antibacterial soap.*

FDA Label Image

Firgure C (Rebif 04)

An illustration showing front and back outlines of a human body with multiple rectangular areas marked on the upper arms, abdomen, and thighs. The diagram likely indicates recommended subcutaneous injection sites for a medication.*

FDA Label Image

Firgure D (Rebif 05)

An instructional illustration showing a hand pinching the skin, likely demonstrating a technique for subcutaneous injection administration.*

FDA Label Image

Firgure E (Rebif 06)

An instructional line drawing showing a hand administering a subcutaneous injection with a syringe into the forearm of another hand. No text is visible in the image.*

FDA Label Image

Firgure F (Rebif 07)

A black and white line drawing illustrating a hand holding a prefilled syringe performing a subcutaneous injection. The syringe needle is positioned at the skin surface, demonstrating injection technique for subcutaneous administration, relevant to injectable medications like REBIF (interferon beta-1a).*

FDA Label Image

Image (Rebif 07a)

Three REBIF (interferon beta-1a) injection solution autoinjectors in subcutaneous dosage form, showing three available strengths: 8.8 mcg/0.2 mL with a green cap, 22 mcg/0.5 mL with a yellow cap, and 44 mcg/0.5 mL with a teal cap. The labeler is EMD Serono, Inc.*

FDA Label Image

Warnings (Rebif 07b)

REBIF 22 mcg/0.5 mL injection, solution for subcutaneous use by EMD Serono, Inc., shown in a glass vial with a yellow cap and a label detailing the product name, strength, and manufacturer.*

FDA Label Image

Image (Rebif 07c)

An instructional diagram of a REBIF prefilled injector pen showing labeled components including the injector button, injector body, dose label area, syringe plunger, transparent syringe housing, and needle cap containing the needle shield. The device is designed for subcutaneous injection of interferon beta-1a solution.*

FDA Label Image

Image (Rebif 07d)

An instructional diagram showing parts of a subcutaneous injection device for REBIF (interferon beta-1a). It identifies the needle cap containing the needle shield, the syringe plunger, the needle, and the safety guard.*

FDA Label Image

Image (Rebif 07e)

REBIF (interferon beta-1a) injection solution 22 mcg and 44 mcg subcutaneous dose cartridges are shown in a prefilled injection device. The 22 mcg cartridge features a yellow cap, while the 44 mcg cartridge has a teal green cap. These cartridge devices are labeled by EMD Serono, Inc., supporting precise dosing for injection use.*

FDA Label Image

Image (Rebif 07f)

An instructional diagram illustrating recommended subcutaneous injection sites for REBIF (interferon beta-1a) on the human body, showing front and back views. Marked areas include the abdomen, thighs, and upper arms for injection placement.*

FDA Label Image

Caution (Rebif 07g)

REBIF 44 mcg/0.5 mL injection solution for subcutaneous use, manufactured by EMD Serono, Inc. The image shows a single-dose prefilled syringe with a green needle cap, labeled with the proprietary name REBIF and strength 44 mcg.*

FDA Label Image

Image (Rebif 07h)

Illustration showing hands demonstrating use of a subcutaneous injection device for REBIF (interferon beta-1a). The first panel (a) depicts attaching a needle to the injection device. The second panel (b) highlights the needle shield on the injection device, indicating safety features for needle handling.*

FDA Label Image

Image (Rebif 07i)

Instructional illustration for using the REBIF injection device. It shows a hand holding the device with guidance to press down on the top button and maintain pressure for 10 seconds, indicating the injection process for the subcutaneous solution.*

FDA Label Image

Image (Rebif 07j)

Illustration showing parts of the REBIF injection device before and after injection, highlighting the position of an internal spring and a safety guard feature. One panel shows the spring compressed before injection and extended after injection, while another panel shows a hand holding the injection device with an arrow indicating removal of the safety guard.*

FDA Label Image

Image (Rebif 07k)

An illustration showing a hand holding a syringe and safely disposing of the needle into a designated sharps container with a biohazard symbol, demonstrating proper disposal technique for injection needles.*

FDA Label Image

Principal Display Panel (Kit Carton-NDC 44087-8822-1)

REBIF Titration Pack injection solution label for subcutaneous use containing interferon beta-1a. It includes 8.8 mcg/0.2 mL and 22 mcg/0.5 mL strengths in single-use prefilled syringes, with a total of 6 syringes of each strength. Labeler is EMD Serono, Inc.*

FDA Label Image

Principal Display Panel (Kit Carton-NDC 44087-0188-1)

REBIF (interferon beta-1a) injection solution in a titration pack for subcutaneous use. The label indicates two strengths: 8.8 mcg/0.2 mL and 22 mcg/0.5 mL, each provided as single-use autoinjectors, six of each strength per package. The label features the EMD Serono logo and instructions for pharmacists regarding the medication guide.*

FDA Label Image

Principal Display Panel (12 Single Use Prefilled Syringe Carton-22 mcg/0.5 mL)

Label for REBIF 22 mcg/0.5 mL injection solution containing interferon beta-1a for subcutaneous use. The label indicates it is prescription only and includes a medication guide for patients. The package contains 12 single-use prefilled syringes. Labeler is EMD Serono, Inc.*

FDA Label Image

Principal Display Panel (12 Single Use Prefilled Syringe Carton-44 mcg/0.5 mL)

REBIF 44 mcg/0.5 mL (interferon beta-1a) injection solution for subcutaneous use is shown on this carton. The label indicates it contains 12 single-use prefilled syringes. Labeler is EMD Serono, Inc. The packaging includes Rx only status and notes a medication guide is enclosed.*

FDA Label Image

Principal Display Panel (12 Single Use Autoinjector Carton-22 mcg / 0.5 mL)

REBIF (interferon beta-1a) Injection 22 mcg/0.5 mL subcutaneous solution label. The label shows this product is supplied as 12 single-use autoinjectors. It includes the manufacturer name EMD Serono, Inc. and emphasizes pharmacy dispensing instructions. The image also depicts a single autoinjector device.*

FDA Label Image

Principal Display Panel (12 Single Use Autoinjector Carton-44 mcg / 0.5 mL)

REBIF Rebiodose interferon beta-1a injection, 44 mcg/0.5 mL, subcutaneous injection. The label indicates a package of 12 single-use autoinjectors by EMD Serono, Inc. The image shows the product name, strength, dosage form, quantity, and a picture of the autoinjector device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.